FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biology and medicine, and concerns a lifespan increasing drug.
EFFECT: substance of the invention involves the use of hyaluronidase immobilised by electron-beam synthesis nanotechnology as a drug for retardation of natural aging and lifespan increase.
1 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
HYPOGLYCEMIC AGENT IN NON-INSULIN-DEPENDENT DIABETES MELLITUS | 2009 |
|
RU2416427C1 |
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
AGENT FOR INCREASING RESERVED STEM CELL NUMBER IN ORGANISM | 2009 |
|
RU2405822C1 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
ANTI-INFLAMMATORY AGENT | 2011 |
|
RU2458126C1 |
ANALGESIC | 2011 |
|
RU2452510C1 |
DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
MEDICATION POSSESSING IMMUNOSTIMULATING AND HEMOSTIMULATING ACTION | 2009 |
|
RU2414223C1 |
Authors
Dates
2012-09-20—Published
2011-02-14—Filed